Pan-European network for the study and clinical management of drug resistant tuberculosis
Category
FP7 Project with U.S. partner
Short name and number
TB PAN-NET (223681)
Area
Health
Description
This proposal will establish an integrated and synergistic network to address the challenge of multiple drug resistant tuberculosis (MDR-TB) facing the EU. The objective will be attained through the establishment of a European consortium of expert partners with extensive experience in the conduct of basic and clinical research relating to MDR-TB, TB control and epidemiology.
Participating Countries
Belgium, Estonia, Finland, France, Germany, Italy, Latvia, Lithuania, Poland, Rumania, Slovenia, Sweden, United Kingdom, United States, Switzerland, Norway and Croatia.
Name of US Partner
University of Medicine and Dentistry of New Jersey
Contact
UNIVERSITA VITA-SALUTE SAN RAFFAELE